# ENZYME BY DESIGN, INC.: Validating the reduced immunogenicity of novel human-like asparaginases to de-risk clinical development

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | ENZYME BY DESIGN, INC. |
| Location | CHICAGO, IL |
| Project | Validating the reduced immunogenicity of novel human-like asparaginases to de-risk clinical development |
| Project number | 1R43CA306391-01A1 |
| Mechanism | R43 |
| Institute | National Cancer Institute |
| Award | $400,000 |
| Awarded | 2026-09-16 |
| Project period | 2026-09-15 to 2027-09-14 |
| UEI | CKUTZNUHGRN7 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11405207). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.